Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)

Condition:   Primary Immune Thrombocytopenia Interventions:   Drug: rhTPO;   Drug: eltrombopag Sponsors:   Wuhan Union Hospital, China;   The First Affiliated Hospital of Nanchang University;   The Third Xiangya Hospital of Central South University;   The First People's Hospital of Yuhang District;   Xiangyang Central Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials